Global Non-invasive Parenteral Screening Instruments Market Growth 2023-2029

February 2023 | 109 pages | ID: G3EB28481F18EN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Non-invasive Parenteral Screening is a nascent genetic process of examining a fetal cell free DNA present in the mothers blood serum for detecting common fetal aneuploidies. Its main objective is early detection of genetic disorders such as trisomy 21 (Down syndrome), trisomy 18 (Edward syndrome), trisomy 13 (Patau syndrome), and monosomy X (Turner syndrome). It can also detect the blood group and rhesus actor of the fetus. Some of the NIPTs currently available in the global market are MaterniT21 PLUS, Harmony, Panorama, NIFTY, PrenaTest, BambniTest, and others.

LPI (LP Information)' newest research report, the “Non-invasive Parenteral Screening Instruments Industry Forecast” looks at past sales and reviews total world Non-invasive Parenteral Screening Instruments sales in 2022, providing a comprehensive analysis by region and market sector of projected Non-invasive Parenteral Screening Instruments sales for 2023 through 2029. With Non-invasive Parenteral Screening Instruments sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Non-invasive Parenteral Screening Instruments industry.

This Insight Report provides a comprehensive analysis of the global Non-invasive Parenteral Screening Instruments landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Non-invasive Parenteral Screening Instruments portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Non-invasive Parenteral Screening Instruments market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Non-invasive Parenteral Screening Instruments and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Non-invasive Parenteral Screening Instruments.

The global Non-invasive Parenteral Screening Instruments market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Non-invasive Parenteral Screening Instruments is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Non-invasive Parenteral Screening Instruments is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Non-invasive Parenteral Screening Instruments is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Non-invasive Parenteral Screening Instruments players cover GE Healthcare, Philips, Illumina, Thermo Fisher Scientific, Roche, PacBio, Perkinelmer, Qiagen and Agilent Technologies, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Non-invasive Parenteral Screening Instruments market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

• Ultrasound Devices
• Next-Generation Sequencing Systems
• Polymerase Chain Reaction Instruments
• Microarrays
• Others

Segmentation by application

• Diagnostic Laboratories
• Hospitals

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• GE Healthcare
• Philips
• Illumina
• Thermo Fisher Scientific
• Roche
• PacBio
• Perkinelmer
• Qiagen
• Agilent Technologies
• BGI Group

Key Questions Addressed in this Report

What is the 10-year outlook for the global Non-invasive Parenteral Screening Instruments market?

What factors are driving Non-invasive Parenteral Screening Instruments market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Non-invasive Parenteral Screening Instruments market opportunities vary by end market size?

How does Non-invasive Parenteral Screening Instruments break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Non-invasive Parenteral Screening Instruments Annual Sales 2018-2029
  2.1.2 World Current & Future Analysis for Non-invasive Parenteral Screening Instruments by Geographic Region, 2018, 2022 & 2029
  2.1.3 World Current & Future Analysis for Non-invasive Parenteral Screening Instruments by Country/Region, 2018, 2022 & 2029
2.2 Non-invasive Parenteral Screening Instruments Segment by Type
  2.2.1 Ultrasound Devices
  2.2.2 Next-Generation Sequencing Systems
  2.2.3 Polymerase Chain Reaction Instruments
  2.2.4 Microarrays
  2.2.5 Others
2.3 Non-invasive Parenteral Screening Instruments Sales by Type
  2.3.1 Global Non-invasive Parenteral Screening Instruments Sales Market Share by Type (2018-2023)
  2.3.2 Global Non-invasive Parenteral Screening Instruments Revenue and Market Share by Type (2018-2023)
  2.3.3 Global Non-invasive Parenteral Screening Instruments Sale Price by Type (2018-2023)
2.4 Non-invasive Parenteral Screening Instruments Segment by Application
  2.4.1 Diagnostic Laboratories
  2.4.2 Hospitals
2.5 Non-invasive Parenteral Screening Instruments Sales by Application
  2.5.1 Global Non-invasive Parenteral Screening Instruments Sale Market Share by Application (2018-2023)
  2.5.2 Global Non-invasive Parenteral Screening Instruments Revenue and Market Share by Application (2018-2023)
  2.5.3 Global Non-invasive Parenteral Screening Instruments Sale Price by Application (2018-2023)

3 GLOBAL NON-INVASIVE PARENTERAL SCREENING INSTRUMENTS BY COMPANY

3.1 Global Non-invasive Parenteral Screening Instruments Breakdown Data by Company
  3.1.1 Global Non-invasive Parenteral Screening Instruments Annual Sales by Company (2018-2023)
  3.1.2 Global Non-invasive Parenteral Screening Instruments Sales Market Share by Company (2018-2023)
3.2 Global Non-invasive Parenteral Screening Instruments Annual Revenue by Company (2018-2023)
  3.2.1 Global Non-invasive Parenteral Screening Instruments Revenue by Company (2018-2023)
  3.2.2 Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Company (2018-2023)
3.3 Global Non-invasive Parenteral Screening Instruments Sale Price by Company
3.4 Key Manufacturers Non-invasive Parenteral Screening Instruments Producing Area Distribution, Sales Area, Product Type
  3.4.1 Key Manufacturers Non-invasive Parenteral Screening Instruments Product Location Distribution
  3.4.2 Players Non-invasive Parenteral Screening Instruments Products Offered
3.5 Market Concentration Rate Analysis
  3.5.1 Competition Landscape Analysis
  3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion

4 WORLD HISTORIC REVIEW FOR NON-INVASIVE PARENTERAL SCREENING INSTRUMENTS BY GEOGRAPHIC REGION

4.1 World Historic Non-invasive Parenteral Screening Instruments Market Size by Geographic Region (2018-2023)
  4.1.1 Global Non-invasive Parenteral Screening Instruments Annual Sales by Geographic Region (2018-2023)
  4.1.2 Global Non-invasive Parenteral Screening Instruments Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Non-invasive Parenteral Screening Instruments Market Size by Country/Region (2018-2023)
  4.2.1 Global Non-invasive Parenteral Screening Instruments Annual Sales by Country/Region (2018-2023)
  4.2.2 Global Non-invasive Parenteral Screening Instruments Annual Revenue by Country/Region (2018-2023)
4.3 Americas Non-invasive Parenteral Screening Instruments Sales Growth
4.4 APAC Non-invasive Parenteral Screening Instruments Sales Growth
4.5 Europe Non-invasive Parenteral Screening Instruments Sales Growth
4.6 Middle East & Africa Non-invasive Parenteral Screening Instruments Sales Growth

5 AMERICAS

5.1 Americas Non-invasive Parenteral Screening Instruments Sales by Country
  5.1.1 Americas Non-invasive Parenteral Screening Instruments Sales by Country (2018-2023)
  5.1.2 Americas Non-invasive Parenteral Screening Instruments Revenue by Country (2018-2023)
5.2 Americas Non-invasive Parenteral Screening Instruments Sales by Type
5.3 Americas Non-invasive Parenteral Screening Instruments Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Non-invasive Parenteral Screening Instruments Sales by Region
  6.1.1 APAC Non-invasive Parenteral Screening Instruments Sales by Region (2018-2023)
  6.1.2 APAC Non-invasive Parenteral Screening Instruments Revenue by Region (2018-2023)
6.2 APAC Non-invasive Parenteral Screening Instruments Sales by Type
6.3 APAC Non-invasive Parenteral Screening Instruments Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan

7 EUROPE

7.1 Europe Non-invasive Parenteral Screening Instruments by Country
  7.1.1 Europe Non-invasive Parenteral Screening Instruments Sales by Country (2018-2023)
  7.1.2 Europe Non-invasive Parenteral Screening Instruments Revenue by Country (2018-2023)
7.2 Europe Non-invasive Parenteral Screening Instruments Sales by Type
7.3 Europe Non-invasive Parenteral Screening Instruments Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Non-invasive Parenteral Screening Instruments by Country
  8.1.1 Middle East & Africa Non-invasive Parenteral Screening Instruments Sales by Country (2018-2023)
  8.1.2 Middle East & Africa Non-invasive Parenteral Screening Instruments Revenue by Country (2018-2023)
8.2 Middle East & Africa Non-invasive Parenteral Screening Instruments Sales by Type
8.3 Middle East & Africa Non-invasive Parenteral Screening Instruments Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 MANUFACTURING COST STRUCTURE ANALYSIS

10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Non-invasive Parenteral Screening Instruments
10.3 Manufacturing Process Analysis of Non-invasive Parenteral Screening Instruments
10.4 Industry Chain Structure of Non-invasive Parenteral Screening Instruments

11 MARKETING, DISTRIBUTORS AND CUSTOMER

11.1 Sales Channel
  11.1.1 Direct Channels
  11.1.2 Indirect Channels
11.2 Non-invasive Parenteral Screening Instruments Distributors
11.3 Non-invasive Parenteral Screening Instruments Customer

12 WORLD FORECAST REVIEW FOR NON-INVASIVE PARENTERAL SCREENING INSTRUMENTS BY GEOGRAPHIC REGION

12.1 Global Non-invasive Parenteral Screening Instruments Market Size Forecast by Region
  12.1.1 Global Non-invasive Parenteral Screening Instruments Forecast by Region (2024-2029)
  12.1.2 Global Non-invasive Parenteral Screening Instruments Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Non-invasive Parenteral Screening Instruments Forecast by Type
12.7 Global Non-invasive Parenteral Screening Instruments Forecast by Application

13 KEY PLAYERS ANALYSIS

13.1 GE Healthcare
  13.1.1 GE Healthcare Company Information
  13.1.2 GE Healthcare Non-invasive Parenteral Screening Instruments Product Portfolios and Specifications
  13.1.3 GE Healthcare Non-invasive Parenteral Screening Instruments Sales, Revenue, Price and Gross Margin (2018-2023)
  13.1.4 GE Healthcare Main Business Overview
  13.1.5 GE Healthcare Latest Developments
13.2 Philips
  13.2.1 Philips Company Information
  13.2.2 Philips Non-invasive Parenteral Screening Instruments Product Portfolios and Specifications
  13.2.3 Philips Non-invasive Parenteral Screening Instruments Sales, Revenue, Price and Gross Margin (2018-2023)
  13.2.4 Philips Main Business Overview
  13.2.5 Philips Latest Developments
13.3 Illumina
  13.3.1 Illumina Company Information
  13.3.2 Illumina Non-invasive Parenteral Screening Instruments Product Portfolios and Specifications
  13.3.3 Illumina Non-invasive Parenteral Screening Instruments Sales, Revenue, Price and Gross Margin (2018-2023)
  13.3.4 Illumina Main Business Overview
  13.3.5 Illumina Latest Developments
13.4 Thermo Fisher Scientific
  13.4.1 Thermo Fisher Scientific Company Information
  13.4.2 Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Product Portfolios and Specifications
  13.4.3 Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Sales, Revenue, Price and Gross Margin (2018-2023)
  13.4.4 Thermo Fisher Scientific Main Business Overview
  13.4.5 Thermo Fisher Scientific Latest Developments
13.5 Roche
  13.5.1 Roche Company Information
  13.5.2 Roche Non-invasive Parenteral Screening Instruments Product Portfolios and Specifications
  13.5.3 Roche Non-invasive Parenteral Screening Instruments Sales, Revenue, Price and Gross Margin (2018-2023)
  13.5.4 Roche Main Business Overview
  13.5.5 Roche Latest Developments
13.6 PacBio
  13.6.1 PacBio Company Information
  13.6.2 PacBio Non-invasive Parenteral Screening Instruments Product Portfolios and Specifications
  13.6.3 PacBio Non-invasive Parenteral Screening Instruments Sales, Revenue, Price and Gross Margin (2018-2023)
  13.6.4 PacBio Main Business Overview
  13.6.5 PacBio Latest Developments
13.7 Perkinelmer
  13.7.1 Perkinelmer Company Information
  13.7.2 Perkinelmer Non-invasive Parenteral Screening Instruments Product Portfolios and Specifications
  13.7.3 Perkinelmer Non-invasive Parenteral Screening Instruments Sales, Revenue, Price and Gross Margin (2018-2023)
  13.7.4 Perkinelmer Main Business Overview
  13.7.5 Perkinelmer Latest Developments
13.8 Qiagen
  13.8.1 Qiagen Company Information
  13.8.2 Qiagen Non-invasive Parenteral Screening Instruments Product Portfolios and Specifications
  13.8.3 Qiagen Non-invasive Parenteral Screening Instruments Sales, Revenue, Price and Gross Margin (2018-2023)
  13.8.4 Qiagen Main Business Overview
  13.8.5 Qiagen Latest Developments
13.9 Agilent Technologies
  13.9.1 Agilent Technologies Company Information
  13.9.2 Agilent Technologies Non-invasive Parenteral Screening Instruments Product Portfolios and Specifications
  13.9.3 Agilent Technologies Non-invasive Parenteral Screening Instruments Sales, Revenue, Price and Gross Margin (2018-2023)
  13.9.4 Agilent Technologies Main Business Overview
  13.9.5 Agilent Technologies Latest Developments
13.10 BGI Group
  13.10.1 BGI Group Company Information
  13.10.2 BGI Group Non-invasive Parenteral Screening Instruments Product Portfolios and Specifications
  13.10.3 BGI Group Non-invasive Parenteral Screening Instruments Sales, Revenue, Price and Gross Margin (2018-2023)
  13.10.4 BGI Group Main Business Overview
  13.10.5 BGI Group Latest Developments

14 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Non-invasive Parenteral Screening Instruments Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Non-invasive Parenteral Screening Instruments Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Ultrasound Devices
Table 4. Major Players of Next-Generation Sequencing Systems
Table 5. Major Players of Polymerase Chain Reaction Instruments
Table 6. Major Players of Microarrays
Table 7. Major Players of Others
Table 8. Global Non-invasive Parenteral Screening Instruments Sales by Type (2018-2023) & (Units)
Table 9. Global Non-invasive Parenteral Screening Instruments Sales Market Share by Type (2018-2023)
Table 10. Global Non-invasive Parenteral Screening Instruments Revenue by Type (2018-2023) & ($ million)
Table 11. Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Type (2018-2023)
Table 12. Global Non-invasive Parenteral Screening Instruments Sale Price by Type (2018-2023) & (USD/Unit)
Table 13. Global Non-invasive Parenteral Screening Instruments Sales by Application (2018-2023) & (Units)
Table 14. Global Non-invasive Parenteral Screening Instruments Sales Market Share by Application (2018-2023)
Table 15. Global Non-invasive Parenteral Screening Instruments Revenue by Application (2018-2023)
Table 16. Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Application (2018-2023)
Table 17. Global Non-invasive Parenteral Screening Instruments Sale Price by Application (2018-2023) & (USD/Unit)
Table 18. Global Non-invasive Parenteral Screening Instruments Sales by Company (2018-2023) & (Units)
Table 19. Global Non-invasive Parenteral Screening Instruments Sales Market Share by Company (2018-2023)
Table 20. Global Non-invasive Parenteral Screening Instruments Revenue by Company (2018-2023) ($ Millions)
Table 21. Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Company (2018-2023)
Table 22. Global Non-invasive Parenteral Screening Instruments Sale Price by Company (2018-2023) & (USD/Unit)
Table 23. Key Manufacturers Non-invasive Parenteral Screening Instruments Producing Area Distribution and Sales Area
Table 24. Players Non-invasive Parenteral Screening Instruments Products Offered
Table 25. Non-invasive Parenteral Screening Instruments Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 26. New Products and Potential Entrants
Table 27. Mergers & Acquisitions, Expansion
Table 28. Global Non-invasive Parenteral Screening Instruments Sales by Geographic Region (2018-2023) & (Units)
Table 29. Global Non-invasive Parenteral Screening Instruments Sales Market Share Geographic Region (2018-2023)
Table 30. Global Non-invasive Parenteral Screening Instruments Revenue by Geographic Region (2018-2023) & ($ millions)
Table 31. Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Geographic Region (2018-2023)
Table 32. Global Non-invasive Parenteral Screening Instruments Sales by Country/Region (2018-2023) & (Units)
Table 33. Global Non-invasive Parenteral Screening Instruments Sales Market Share by Country/Region (2018-2023)
Table 34. Global Non-invasive Parenteral Screening Instruments Revenue by Country/Region (2018-2023) & ($ millions)
Table 35. Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Country/Region (2018-2023)
Table 36. Americas Non-invasive Parenteral Screening Instruments Sales by Country (2018-2023) & (Units)
Table 37. Americas Non-invasive Parenteral Screening Instruments Sales Market Share by Country (2018-2023)
Table 38. Americas Non-invasive Parenteral Screening Instruments Revenue by Country (2018-2023) & ($ Millions)
Table 39. Americas Non-invasive Parenteral Screening Instruments Revenue Market Share by Country (2018-2023)
Table 40. Americas Non-invasive Parenteral Screening Instruments Sales by Type (2018-2023) & (Units)
Table 41. Americas Non-invasive Parenteral Screening Instruments Sales by Application (2018-2023) & (Units)
Table 42. APAC Non-invasive Parenteral Screening Instruments Sales by Region (2018-2023) & (Units)
Table 43. APAC Non-invasive Parenteral Screening Instruments Sales Market Share by Region (2018-2023)
Table 44. APAC Non-invasive Parenteral Screening Instruments Revenue by Region (2018-2023) & ($ Millions)
Table 45. APAC Non-invasive Parenteral Screening Instruments Revenue Market Share by Region (2018-2023)
Table 46. APAC Non-invasive Parenteral Screening Instruments Sales by Type (2018-2023) & (Units)
Table 47. APAC Non-invasive Parenteral Screening Instruments Sales by Application (2018-2023) & (Units)
Table 48. Europe Non-invasive Parenteral Screening Instruments Sales by Country (2018-2023) & (Units)
Table 49. Europe Non-invasive Parenteral Screening Instruments Sales Market Share by Country (2018-2023)
Table 50. Europe Non-invasive Parenteral Screening Instruments Revenue by Country (2018-2023) & ($ Millions)
Table 51. Europe Non-invasive Parenteral Screening Instruments Revenue Market Share by Country (2018-2023)
Table 52. Europe Non-invasive Parenteral Screening Instruments Sales by Type (2018-2023) & (Units)
Table 53. Europe Non-invasive Parenteral Screening Instruments Sales by Application (2018-2023) & (Units)
Table 54. Middle East & Africa Non-invasive Parenteral Screening Instruments Sales by Country (2018-2023) & (Units)
Table 55. Middle East & Africa Non-invasive Parenteral Screening Instruments Sales Market Share by Country (2018-2023)
Table 56. Middle East & Africa Non-invasive Parenteral Screening Instruments Revenue by Country (2018-2023) & ($ Millions)
Table 57. Middle East & Africa Non-invasive Parenteral Screening Instruments Revenue Market Share by Country (2018-2023)
Table 58. Middle East & Africa Non-invasive Parenteral Screening Instruments Sales by Type (2018-2023) & (Units)
Table 59. Middle East & Africa Non-invasive Parenteral Screening Instruments Sales by Application (2018-2023) & (Units)
Table 60. Key Market Drivers & Growth Opportunities of Non-invasive Parenteral Screening Instruments
Table 61. Key Market Challenges & Risks of Non-invasive Parenteral Screening Instruments
Table 62. Key Industry Trends of Non-invasive Parenteral Screening Instruments
Table 63. Non-invasive Parenteral Screening Instruments Raw Material
Table 64. Key Suppliers of Raw Materials
Table 65. Non-invasive Parenteral Screening Instruments Distributors List
Table 66. Non-invasive Parenteral Screening Instruments Customer List
Table 67. Global Non-invasive Parenteral Screening Instruments Sales Forecast by Region (2024-2029) & (Units)
Table 68. Global Non-invasive Parenteral Screening Instruments Revenue Forecast by Region (2024-2029) & ($ millions)
Table 69. Americas Non-invasive Parenteral Screening Instruments Sales Forecast by Country (2024-2029) & (Units)
Table 70. Americas Non-invasive Parenteral Screening Instruments Revenue Forecast by Country (2024-2029) & ($ millions)
Table 71. APAC Non-invasive Parenteral Screening Instruments Sales Forecast by Region (2024-2029) & (Units)
Table 72. APAC Non-invasive Parenteral Screening Instruments Revenue Forecast by Region (2024-2029) & ($ millions)
Table 73. Europe Non-invasive Parenteral Screening Instruments Sales Forecast by Country (2024-2029) & (Units)
Table 74. Europe Non-invasive Parenteral Screening Instruments Revenue Forecast by Country (2024-2029) & ($ millions)
Table 75. Middle East & Africa Non-invasive Parenteral Screening Instruments Sales Forecast by Country (2024-2029) & (Units)
Table 76. Middle East & Africa Non-invasive Parenteral Screening Instruments Revenue Forecast by Country (2024-2029) & ($ millions)
Table 77. Global Non-invasive Parenteral Screening Instruments Sales Forecast by Type (2024-2029) & (Units)
Table 78. Global Non-invasive Parenteral Screening Instruments Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 79. Global Non-invasive Parenteral Screening Instruments Sales Forecast by Application (2024-2029) & (Units)
Table 80. Global Non-invasive Parenteral Screening Instruments Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 81. GE Healthcare Basic Information, Non-invasive Parenteral Screening Instruments Manufacturing Base, Sales Area and Its Competitors
Table 82. GE Healthcare Non-invasive Parenteral Screening Instruments Product Portfolios and Specifications
Table 83. GE Healthcare Non-invasive Parenteral Screening Instruments Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 84. GE Healthcare Main Business
Table 85. GE Healthcare Latest Developments
Table 86. Philips Basic Information, Non-invasive Parenteral Screening Instruments Manufacturing Base, Sales Area and Its Competitors
Table 87. Philips Non-invasive Parenteral Screening Instruments Product Portfolios and Specifications
Table 88. Philips Non-invasive Parenteral Screening Instruments Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 89. Philips Main Business
Table 90. Philips Latest Developments
Table 91. Illumina Basic Information, Non-invasive Parenteral Screening Instruments Manufacturing Base, Sales Area and Its Competitors
Table 92. Illumina Non-invasive Parenteral Screening Instruments Product Portfolios and Specifications
Table 93. Illumina Non-invasive Parenteral Screening Instruments Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 94. Illumina Main Business
Table 95. Illumina Latest Developments
Table 96. Thermo Fisher Scientific Basic Information, Non-invasive Parenteral Screening Instruments Manufacturing Base, Sales Area and Its Competitors
Table 97. Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Product Portfolios and Specifications
Table 98. Thermo Fisher Scientific Non-invasive Parenteral Screening Instruments Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 99. Thermo Fisher Scientific Main Business
Table 100. Thermo Fisher Scientific Latest Developments
Table 101. Roche Basic Information, Non-invasive Parenteral Screening Instruments Manufacturing Base, Sales Area and Its Competitors
Table 102. Roche Non-invasive Parenteral Screening Instruments Product Portfolios and Specifications
Table 103. Roche Non-invasive Parenteral Screening Instruments Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 104. Roche Main Business
Table 105. Roche Latest Developments
Table 106. PacBio Basic Information, Non-invasive Parenteral Screening Instruments Manufacturing Base, Sales Area and Its Competitors
Table 107. PacBio Non-invasive Parenteral Screening Instruments Product Portfolios and Specifications
Table 108. PacBio Non-invasive Parenteral Screening Instruments Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 109. PacBio Main Business
Table 110. PacBio Latest Developments
Table 111. Perkinelmer Basic Information, Non-invasive Parenteral Screening Instruments Manufacturing Base, Sales Area and Its Competitors
Table 112. Perkinelmer Non-invasive Parenteral Screening Instruments Product Portfolios and Specifications
Table 113. Perkinelmer Non-invasive Parenteral Screening Instruments Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 114. Perkinelmer Main Business
Table 115. Perkinelmer Latest Developments
Table 116. Qiagen Basic Information, Non-invasive Parenteral Screening Instruments Manufacturing Base, Sales Area and Its Competitors
Table 117. Qiagen Non-invasive Parenteral Screening Instruments Product Portfolios and Specifications
Table 118. Qiagen Non-invasive Parenteral Screening Instruments Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 119. Qiagen Main Business
Table 120. Qiagen Latest Developments
Table 121. Agilent Technologies Basic Information, Non-invasive Parenteral Screening Instruments Manufacturing Base, Sales Area and Its Competitors
Table 122. Agilent Technologies Non-invasive Parenteral Screening Instruments Product Portfolios and Specifications
Table 123. Agilent Technologies Non-invasive Parenteral Screening Instruments Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 124. Agilent Technologies Main Business
Table 125. Agilent Technologies Latest Developments
Table 126. BGI Group Basic Information, Non-invasive Parenteral Screening Instruments Manufacturing Base, Sales Area and Its Competitors
Table 127. BGI Group Non-invasive Parenteral Screening Instruments Product Portfolios and Specifications
Table 128. BGI Group Non-invasive Parenteral Screening Instruments Sales (Units), Revenue ($ Million), Price (USD/Unit) and Gross Margin (2018-2023)
Table 129. BGI Group Main Business
Table 130. BGI Group Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Picture of Non-invasive Parenteral Screening Instruments
Figure 2. Non-invasive Parenteral Screening Instruments Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Non-invasive Parenteral Screening Instruments Sales Growth Rate 2018-2029 (Units)
Figure 7. Global Non-invasive Parenteral Screening Instruments Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Non-invasive Parenteral Screening Instruments Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Ultrasound Devices
Figure 10. Product Picture of Next-Generation Sequencing Systems
Figure 11. Product Picture of Polymerase Chain Reaction Instruments
Figure 12. Product Picture of Microarrays
Figure 13. Product Picture of Others
Figure 14. Global Non-invasive Parenteral Screening Instruments Sales Market Share by Type in 2022
Figure 15. Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Type (2018-2023)
Figure 16. Non-invasive Parenteral Screening Instruments Consumed in Diagnostic Laboratories
Figure 17. Global Non-invasive Parenteral Screening Instruments Market: Diagnostic Laboratories (2018-2023) & (Units)
Figure 18. Non-invasive Parenteral Screening Instruments Consumed in Hospitals
Figure 19. Global Non-invasive Parenteral Screening Instruments Market: Hospitals (2018-2023) & (Units)
Figure 20. Global Non-invasive Parenteral Screening Instruments Sales Market Share by Application (2022)
Figure 21. Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Application in 2022
Figure 22. Non-invasive Parenteral Screening Instruments Sales Market by Company in 2022 (Units)
Figure 23. Global Non-invasive Parenteral Screening Instruments Sales Market Share by Company in 2022
Figure 24. Non-invasive Parenteral Screening Instruments Revenue Market by Company in 2022 ($ Million)
Figure 25. Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Company in 2022
Figure 26. Global Non-invasive Parenteral Screening Instruments Sales Market Share by Geographic Region (2018-2023)
Figure 27. Global Non-invasive Parenteral Screening Instruments Revenue Market Share by Geographic Region in 2022
Figure 28. Americas Non-invasive Parenteral Screening Instruments Sales 2018-2023 (Units)
Figure 29. Americas Non-invasive Parenteral Screening Instruments Revenue 2018-2023 ($ Millions)
Figure 30. APAC Non-invasive Parenteral Screening Instruments Sales 2018-2023 (Units)
Figure 31. APAC Non-invasive Parenteral Screening Instruments Revenue 2018-2023 ($ Millions)
Figure 32. Europe Non-invasive Parenteral Screening Instruments Sales 2018-2023 (Units)
Figure 33. Europe Non-invasive Parenteral Screening Instruments Revenue 2018-2023 ($ Millions)
Figure 34. Middle East & Africa Non-invasive Parenteral Screening Instruments Sales 2018-2023 (Units)
Figure 35. Middle East & Africa Non-invasive Parenteral Screening Instruments Revenue 2018-2023 ($ Millions)
Figure 36. Americas Non-invasive Parenteral Screening Instruments Sales Market Share by Country in 2022
Figure 37. Americas Non-invasive Parenteral Screening Instruments Revenue Market Share by Country in 2022
Figure 38. Americas Non-invasive Parenteral Screening Instruments Sales Market Share by Type (2018-2023)
Figure 39. Americas Non-invasive Parenteral Screening Instruments Sales Market Share by Application (2018-2023)
Figure 40. United States Non-invasive Parenteral Screening Instruments Revenue Growth 2018-2023 ($ Millions)
Figure 41. Canada Non-invasive Parenteral Screening Instruments Revenue Growth 2018-2023 ($ Millions)
Figure 42. Mexico Non-invasive Parenteral Screening Instruments Revenue Growth 2018-2023 ($ Millions)
Figure 43. Brazil Non-invasive Parenteral Screening Instruments Revenue Growth 2018-2023 ($ Millions)
Figure 44. APAC Non-invasive Parenteral Screening Instruments Sales Market Share by Region in 2022
Figure 45. APAC Non-invasive Parenteral Screening Instruments Revenue Market Share by Regions in 2022
Figure 46. APAC Non-invasive Parenteral Screening Instruments Sales Market Share by Type (2018-2023)
Figure 47. APAC Non-invasive Parenteral Screening Instruments Sales Market Share by Application (2018-2023)
Figure 48. China Non-invasive Parenteral Screening Instruments Revenue Growth 2018-2023 ($ Millions)
Figure 49. Japan Non-invasive Parenteral Screening Instruments Revenue Growth 2018-2023 ($ Millions)
Figure 50. South Korea Non-invasive Parenteral Screening Instruments Revenue Growth 2018-2023 ($ Millions)
Figure 51. Southeast Asia Non-invasive Parenteral Screening Instruments Revenue Growth 2018-2023 ($ Millions)
Figure 52. India Non-invasive Parenteral Screening Instruments Revenue Growth 2018-2023 ($ Millions)
Figure 53. Australia Non-invasive Parenteral Screening Instruments Revenue Growth 2018-2023 ($ Millions)
Figure 54. China Taiwan Non-invasive Parenteral Screening Instruments Revenue Growth 2018-2023 ($ Millions)
Figure 55. Europe Non-invasive Parenteral Screening Instruments Sales Market Share by Country in 2022
Figure 56. Europe Non-invasive Parenteral Screening Instruments Revenue Market Share by Country in 2022
Figure 57. Europe Non-invasive Parenteral Screening Instruments Sales Market Share by Type (2018-2023)
Figure 58. Europe Non-invasive Parenteral Screening Instruments Sales Market Share by Application (2018-2023)
Figure 59. Germany Non-invasive Parenteral Screening Instruments Revenue Growth 2018-2023 ($ Millions)
Figure 60. France Non-invasive Parenteral Screening Instruments Revenue Growth 2018-2023 ($ Millions)
Figure 61. UK Non-invasive Parenteral Screening Instruments Revenue Growth 2018-2023 ($ Millions)
Figure 62. Italy Non-invasive Parenteral Screening Instruments Revenue Growth 2018-2023 ($ Millions)
Figure 63. Russia Non-invasive Parenteral Screening Instruments Revenue Growth 2018-2023 ($ Millions)
Figure 64. Middle East & Africa Non-invasive Parenteral Screening Instruments Sales Market Share by Country in 2022
Figure 65. Middle East & Africa Non-invasive Parenteral Screening Instruments Revenue Market Share by Country in 2022
Figure 66. Middle East & Africa Non-invasive Parenteral Screening Instruments Sales Market Share by Type (2018-2023)
Figure 67. Middle East & Africa Non-invasive Parenteral Screening Instruments Sales Market Share by Application (2018-2023)
Figure 68. Egypt Non-invasive Parenteral Screening Instruments Revenue Growth 2018-2023 ($ Millions)
Figure 69. South Africa Non-invasive Parenteral Screening Instruments Revenue Growth 2018-2023 ($ Millions)
Figure 70. Israel Non-invasive Parenteral Screening Instruments Revenue Growth 2018-2023 ($ Millions)
Figure 71. Turkey Non-invasive Parenteral Screening Instruments Revenue Growth 2018-2023 ($ Millions)
Figure 72. GCC Country Non-invasive Parenteral Screening Instruments Revenue Growth 2018-2023 ($ Millions)
Figure 73. Manufacturing Cost Structure Analysis of Non-invasive Parenteral Screening Instruments in 2022
Figure 74. Manufacturing Process Analysis of Non-invasive Parenteral Screening Instruments
Figure 75. Industry Chain Structure of Non-invasive Parenteral Screening Instruments
Figure 76. Channels of Distribution
Figure 77. Global Non-invasive Parenteral Screening Instruments Sales Market Forecast by Region (2024-2029)
Figure 78. Global Non-invasive Parenteral Screening Instruments Revenue Market Share Forecast by Region (2024-2029)
Figure 79. Global Non-invasive Parenteral Screening Instruments Sales Market Share Forecast by Type (2024-2029)
Figure 80. Global Non-invasive Parenteral Screening Instruments Revenue Market Share Forecast by Type (2024-2029)
Figure 81. Global Non-invasive Parenteral Screening Instruments Sales Market Share Forecast by Application (2024-2029)
Figure 82. Global Non-invasive Parenteral Screening Instruments Revenue Market Share Forecast by Application (2024-2029)